The Scotts Miracle-Gro Company SMG reported a second-quarter fiscal 2025 (ended March 29, 2025) profit of $217.5 million or $3.72 per share, roughly 38% higher than $157.5 million or $2.74 per share in the prior-year quarter. Barring one-time items, the adjusted earnings were $3.98 per share compared with $3.69 a year ago, topping the Zacks Consensus Estimate of $3.95. The company’s net sales in the fiscal second quarter were $1,421 million, which missed the Zacks Consensus Estimate of $1,498.2 million. Net sales declined around 6.8% year over year. U.S. Consumer sales fell as a result of a colder and slower start to the lawn and garden season, pushing some expected second-quarter sales into the third quarter, as well as due to non-recurring fiscal 2024 net sales of bulk raw materials and AeroGarden products. (Find the latest EPS estimates and surprises on Zacks Earnings Calendar.) The Scotts Miracle-Gro Company Price, Consensus and EPS Surprise The Scotts Miracle-Gro Company price-consensus-eps-surprise-chart | The Scotts Miracle-Gro Company Quote SMG’s Segment Highlights In the fiscal second quarter, net sales in the U.S. Consumer division were down 5% year over year to $1,311.5 million, missing our estimate of $1,373.2 million. The segment recorded a profit of $392.5 million, up 2% year over year. Net sales in the Hawthorne segment tumbled 51% year over year to $32.7 million in the reported quarter, missing our estimate of $70.4 million. The segment reported a loss of $0.9 million. The figure was narrower than the year-ago loss of $3.4 million. Net sales in the other segment fell 3% year over year to $76.8 million, beating our estimate of $62.3 million. The segment reported a profit of $9 million, up 41%. SMG’s Financials At the end of the fiscal second quarter, SMG had cash and cash equivalents of $16.9 million, down around 74% year over year. Long-term debt decreased roughly 9.7% to $2,493.2 million. SMG’s Outlook The company reiterated its previously stated guidance for U.S. Consumer segment net sales, adjusted gross margin, adjusted EBITDA and free cash flow. Given the ongoing uncertainty in the cannabis business, the company is no longer issuing full-year revenue guidance for its Hawthorne segment. SMG’s Price Performance SMG’s shares are down 23.7% over a year compared with an 10.1% fall recorded by its industry.Zacks Investment Research Image Source: Zacks Investment Research SMG’s Zacks Rank & Key Picks SMG currently carries a Zacks Rank #3 (Hold). Better-ranked stocks worth a look in the basic materials space include Hawkins, Inc. HWKN, SSR Mining Inc. SSRM and Coeur Mining CDE. While HWKN and CDE carry a Zacks Rank #1 (Strong Buy), SSRM has a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here. Hawkins is scheduled to report fiscal fourth-quarter results on May 14. The consensus estimate for Hawkins’ earnings is pegged at 74 cents. HWKN beat the consensus estimate in one of the last four quarters while missing thrice, with the average earnings surprise being 6.1%. SSRM is scheduled to release first-quarter results on May 6. The Zacks Consensus Estimate for SSRM’s first-quarter earnings is pegged at 8 cents. SSRM has a trailing four-quarter earnings surprise of 155.7%, on average. Coeur Mining is slated to release first-quarter results on May 7. CDE has a trailing four-quarter earnings surprise of 27.9%, on average. Story Continues Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report The Scotts Miracle-Gro Company (SMG):Free Stock Analysis Report Coeur Mining, Inc. (CDE):Free Stock Analysis Report Silver Standard Resources Inc. (SSRM):Free Stock Analysis Report Hawkins, Inc. (HWKN):Free Stock Analysis Report This article originally published on Zacks Investment Research (zacks.com). Zacks Investment Research View Comments
Scotts Miracle-Gro Q2 Earnings Surpass Estimates, Sales Miss
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...